The rise of Viagra initially sparked a surge for pharma, but recent changes present a uncertain picture for shareholders. Generic versions are eroding revenue, and continued legal battles add additional risk to the https://kiarajgcm372197.bloggip.com/41597144/the-blue-pill-and-pharma-a-risky-investment